126 related articles for article (PubMed ID: 8703433)
21. Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.
Legros V; Jolivet-Reynaud C; Battail-Poirot N; Saint-Pierre C; Forest E
Protein Sci; 2000 May; 9(5):1002-10. PubMed ID: 10850810
[TBL] [Abstract][Full Text] [Related]
22. Expression and secretion of recombinant outer-surface protein A from the Lyme disease agent, Borrelia burgdorferi, in Nicotiana tabacum suspension cells.
Navarre C; Delannoy M; Lefebvre B; Nader J; Vanham D; Boutry M
Transgenic Res; 2006 Jun; 15(3):325-35. PubMed ID: 16779648
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
24. Preparation and purification of recombinant outer surface protein A (rOspA) of Borrelia burgdorferi sensu stricto and Borrelia afzelii.
Bĕláková J; Krupka M; Sebestová M; Tuhácková J; Vrzal V; Raska M; Weigl E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):257-9. PubMed ID: 16601765
[TBL] [Abstract][Full Text] [Related]
25. Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.
Jiang W; Gorevic PD; Dattwyler RJ; Dunn JJ; Luft BJ
Clin Diagn Lab Immunol; 1994 Jul; 1(4):406-12. PubMed ID: 8556477
[TBL] [Abstract][Full Text] [Related]
26. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
[TBL] [Abstract][Full Text] [Related]
27. Evidence for an alpha-helical epitope on outer surface protein A from the Lyme disease spirochete, Borrelia burgdorferi: an application of steady-state and time-resolved fluorescence quenching techniques.
France LL; Kieleczawa J; Dunn JJ; Luft BJ; Hind G; Sutherland JC
Biochim Biophys Acta; 1993 Oct; 1202(2):287-96. PubMed ID: 7691186
[TBL] [Abstract][Full Text] [Related]
28. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
29. Lyme borreliosis in transgenic mice tolerant to OspA from Borrelia burgdorferi 25015.
Fikrig E; Barthold SW; Chen M; Tao H; Ali-Salaam P; Bockenstedt LK; Flavell RA
J Infect Dis; 1997 Apr; 175(4):1000-3. PubMed ID: 9086169
[TBL] [Abstract][Full Text] [Related]
30. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
Molloy PJ; Berardi VP; Persing DH; Sigal LH
Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
[TBL] [Abstract][Full Text] [Related]
31. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
Comstedt P; Schüler W; Meinke A; Lundberg U
PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
[TBL] [Abstract][Full Text] [Related]
32. Expression and secretion of outer surface protein (OSP-A) of Borrelia burgdorferi from Escherichia coli.
Chang YF; Lauderdale TL; Lee WY; Shin SJ; Jacobson RH; Appel MJ; Lein DH
FEMS Microbiol Lett; 1993 May; 109(2-3):297-301. PubMed ID: 8339919
[TBL] [Abstract][Full Text] [Related]
33. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
34. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
35. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes.
Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R
Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS
J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199
[TBL] [Abstract][Full Text] [Related]
37. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
38. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J
Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340
[TBL] [Abstract][Full Text] [Related]
39. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
[TBL] [Abstract][Full Text] [Related]
40. The Lyme disease vaccine takes its toll.
Thomas V; Fikrig E
Vector Borne Zoonotic Dis; 2002; 2(4):217-22. PubMed ID: 12804162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
